Clinical Trial Update: Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating pravastatin for survival and recurrence in advanced gastroesophageal cancer has an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Pravastatin (pravastatin)

Snippet

Sponsor: Hospital Donostia | Conditions: Esophageal Cancer, Stomach Cancer | Phase 4 | Status: UNKNOWN